Results 141 to 150 of about 7,233,987 (192)

Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. [PDF]

J Endocrinol Invest
Baroncelli GI, Barale M, Brandi ML, Camozzi V, Carrara S, Nicoletti MC, Castellano E, Cetani F, Comberiati P, Iorgi ND, Eller-Vainicher C, Emma F, Fintini D, Giannini S, Gianotti L, Grandone A, Grassi G, Mora S, Palermo A, Pigliaru F, Pitea M, Procopio M, Rochira V, Ruggeri RM, Ruggiero B, Stagi S, Vezzoli G, Corbetta S.   +27 more
europepmc   +1 more source

Patient and carer perceptions and acceptability of current management practices in paediatric X-linked hypophosphatemia treated with burosumab therapy. [PDF]

JBMR Plus
Sandy JL, Rodda CP, Siafarikas A, Biggin A, Wall CL, Collins L, Schindeler A, Simm PJ, Munns CF.   +8 more
europepmc   +1 more source

Two-year structural skeletal outcomes of burosumab therapy in pediatric X-linked hypophosphatemia: A radiographic cohort study. [PDF]

J Child Orthop
Lim H, Lee W, Choi N, Lee YJ, Shin CH, Lee YA, Ko JM, Song MH.   +7 more
europepmc   +1 more source

Improvement in Physical Function Associated With Burosumab in a Patient With X-linked Hypophosphatemia: A Case Report. [PDF]

Cureus
Fukushima M, Hashida R, Matsuse H, Hiraoka K.   +3 more
europepmc   +1 more source

Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia. [PDF]

Calcif Tissue Int
Böckmann I, Leifheit-Nestler M, Rehberg M, Spartà G, Evers K, Schlingmann KP, Kemper MJ, Richter-Unruh A, Hiort O, Grohmann-Held K, Derichs U, Freiberg C, Weitz M, Dunstheimer D, Schmid E, John-Kroegel U, Metzing O, Heger S, Jorch N, Staude H, Patzer L, Wühl E, Zivicnjak M, Schnabel D, Haffner D, German Society for Pediatric Nephrology (GPN) and the German Society for Pediatric and Adolescent Endocrinology and Diabetology (DGPAED).   +25 more
europepmc   +1 more source

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells. [PDF]

Calcif Tissue Int
Falsetti I, Palmini G, Donati S, Aurilia C, Zonefrati R, Di Filippo L, Giustina A, Giannini S, Arcidiacono GP, Iantomasi T, Lazzerini D, Joos-Vandewalle P, Lee C, Brandi ML.   +13 more
europepmc   +1 more source

X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab. [PDF]

Orphanet J Rare Dis
Brandi ML, Vainicher CE, Fintini D, Giusti A, Magnolato A, Minisola S, Giannini S.   +6 more
europepmc   +1 more source

Factors associated with impaired physical functionality in X-linked hypophosphatemia. [PDF]

JBMR Plus
Ivanovic-Zuvic D, Madison A, Jiménez M, Oyanadel ML, Gattini N, Guzmán C, Cifré M, Silvestre R, García C, Contreras O, Collins MT, Florenzano P.   +11 more
europepmc   +1 more source

Real-world characteristics & disease history of patients with X-linked hypophosphatemia before treatment with burosumab. [PDF]

Arch Osteoporos
Dahir KM, Li Z, Heerssen HM, Noman A, Kim J, Zhao Y, Imel EA.   +6 more
europepmc   +1 more source

Inadequate pediatric reference ranges impede the diagnosis of X-linked hypophosphatemia and hypophosphatasia in Austria. [PDF]

Wien Klin Wochenschr
Steininger J, Jablonska M, Sagmeister S, Mindler G, Raimann A.   +4 more
europepmc   +1 more source